The BaseLaunch accelerator is tailored to the needs of healthcare startups.
Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
The BaseLaunch accelerator supports carefully selected ventures over the course of 15 months and runs in two phases. It provides non-dilutive funding, no strings attached access to its Healthcare Partners, knowledge from highly experienced advisors, as well as a state-of-the-art infrastructure. Furthermore, Baselaunch embeds the ventures deeply within the Basel region, one of Europe’s finest biotech ecosystem. Baselaunch is backed by five industry leaders — Johnson &a; Johnson Innovation, Novartis Venture Fund, Pfizer, Roche and Roivant Sciences — as well as by other public and private partners.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
2/2022 | Engimmune Therapeutics | Pre Seed Round | 0 |
2/2022 | Aukera Therapeutics | Pre Seed Round | 0 |
1/2020 | PharmaBiome | Seed Round | - |
1/2022 | Stromal Therapeutics | Seed Round | 536.9k |
1/2018 | POLYNEURON | Grant | 0 |
2/2022 | Engimmune Therapeutics | Pre Seed Round | 0 |
2/2022 | Aukera Therapeutics | Pre Seed Round | 0 |
1/2022 | Stromal Therapeutics | Seed Round | 0 |
1/2020 | PharmaBiome | Seed Round | - |
1/2018 | POLYNEURON | Grant | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|